Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: Reuters Investment Profile
$20.00
Provider: Wright Reports
$75.00
Provider: GlobalData
$125.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Neuren Pharmaceuticals Ltd Completes New Share Placement Of $21.5 Million


Tuesday, 22 Oct 2013 02:00am EDT 

Neuren Pharmaceuticals Ltd announced that it has completed a placement of new shares to professional and sophisticated investors at $0.115 per share, providing additional capital of $21.5 million. The placement was heavily over-subscribed, an indication of the strong support from international and domestic institutional investors. Neuren also intends to offer a Share Purchase Plan at $0.115 per share, capped at $3 million, to shareholders registered at 7pm AEST on October 18, 2013. 

Company Quote

0.115
 --
19 Dec 2014